CCL2/MCP-I genotype-phenotype relationship in latent tuberculosis infection

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Hussain, Rabia ^a   Ansari, Ambreen ^a   Talat, Najeeha ^a   Hasan, Zahra ^a   Dawood, Ghaffar ^b  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b Masoomeen Trust Hospital   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, HUMAN;

ADULT; ARTICLE; CCL2 PROTEIN LEVEL; CONTROLLED STUDY; FEMALE; GENOTYPE PHENOTYPE CORRELATION; GRANULOMA; HUMAN; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULIN TEST; ALLELE; BLOOD; CASE CONTROL STUDY; DEMOGRAPHY; FAMILY SIZE; GENETIC ASSOCIATION; GENETICS; GENOTYPE; HEALTH;

ADULT; ALLELES; CASE-CONTROL STUDIES; CHEMOKINE CCL2; FAMILY CHARACTERISTICS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HEALTH; HUMANS; LATENT TUBERCULOSIS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RESIDENCE CHARACTERISTICS; ROC CURVE; TUBERCULIN TEST;

EID: 80053520425     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025803     Document Type: Article

References (38)

1. Rathi SK, Akhtar S, Rahbar MH, Azam SI, (2002) Prevalence and risk factors associated with tuberculin skin test positivity among household contacts of smear-positive pulnionary tuberculosis cases in Umerkot, Pakistan. Int J Tuberc Lung Dis 6: 851-857.
2. Hussain R, Talat N, Shahid F, Dawood G, (2009) Biomarker changes associated with Tuberculin Skin Test (TST) conversion: a two-year longitudinal follow-up study in exposed household contacts. PLoS ONE 4: e7444.
3. Gale LM, McColl SR, (1999) Chemokines: extracellular messengers for all occasions? Bioessays 21: 17-28.
4. Deshmane SL, Kremlev S, Amini S, Sawaya BE, (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29: 313-326.
5. Rovin BH, Lu L, Saxena R, (1999) A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259: 344-348.
6. Flores-Villanueva PO, Ruiz-Morales JA, Song CH, Flores LM, Jo EK, et al. (2005) A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 202: 1649-1658.
7. Ben-Selma W, Harizi H, Boukadida J, (2011) MCP-1-2518 A/G functional polymorphism is associated with increased susceptibility to active pulmonary tuberculosis in Tunisian patients. Mol Biol Rep DOI 10.1007/s11033-011-0695-4.
8. Chu SF, Tam CM, Wong HS, Kam KM, Lau YL, et al. (2007) Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese. Genes Immun 8: 475-479.
9. Alagarasu K, Selvaraj P, Swaminathan S, Raghavan S, Narendran G, et al. (2009) CCR2, MCP-1, SDF-1a & DC-SIGN gene polymorphisms in HIV-1 infected patients with & without tuberculosis. Indian J Med Res 130: 444-450.
10. Moller M, Nebel A, Valentonyte R, van Helden PD, Schreiber S, et al. (2009) Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population. Tuberculosis (Edinb) 89: 189-194.
11. Larcombe LA, Orr PH, Lodge AM, Brown JS, Dembinski IJ, et al. (2008) Functional gene polymorphisms in canadian aboriginal populations with high rates of tuberculosis. J Infect Dis 198: 1175-1179.
12. Thye T, Nejentsev S, Intemann CD, Browne EN, Chinbuah MA, et al. (2009) MCP-1 promoter variant-362C associated with protection from pulmonary tuberculosis in Ghana, West Africa. Hum Mol Genet 18: 381-388.
13. Xu ZE, Xie YY, Chen JH, Xing LL, Zhang AH, et al. (2009) [Monocyte chemotactic protein-1 gene polymorphism and monocyte chemotactic protein-1 expression in Chongqing Han children with tuberculosis]. Zhonghua Er Ke Za Zhi 47: 200-203.
14. Buijtels PC, van de Sande WW, Parkinson S, Petit PL, van der Sande MA, et al. (2008) Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia. Int J Tuberc Lung Dis 12: 1485-1488.
15. Crofton J, (1990) Crofton and Douglas Respiratory Diseases. Clinical features of tuberculosis London Blackwell Scientific pp. 395-421.
16. Ansari A, Talat N, Jamil B, Hasan Z, Razzaki T, et al. (2009) Cytokine gene polymorphisms across tuberculosis clinical spectrum in Pakistani patients. PLoS ONE 4: e4778.
17. Talat N, Shahid F, Dawood G, Hussain R, (2009) Dynamic changes in biomarker profiles associated with clinical and subclinical tuberculosis in a high transmission setting: a four-year follow-up study. Scand J Immunol 69: 537-546.
18. Cardona PJ, (2009) A dynamic reinfection hypothesis of latent tuberculosis infection. Infection 37: 80-86.
19. Denkinger CM, Dheda K, Pai M, (2011) Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 17: 806-814.
20. Menzies D, Pai M, Comstock G, (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354.
21. Mendez-Samperio P, (2008) Expression and regulation of chemokines in mycoabcterial infection. Journal of Infection 57: 374-384.
22. Liu M, Guo S, Hibbert JM, Jain V, Singh N, et al. (2011) CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev 2011 Jun;22 (3): 121-30.
23. Hasan Z, Cliff JM, Dockrell HM, Jamil B, Irfan M, et al. (2009) CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis. PLoS ONE 4: e8459.
24. Hasan Z, Jamil B, Ashraf M, Islam M, Yusuf MS, et al. (2009) ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis. PLoS ONE 4: e5158.
25. Hasan Z, Jamil B, Zaidi I, Zafar S, Khan AA, et al. (2006) Elevated Serum CCL2 concomitant with a reduced Mycobacterium-induced response leads to disease dissemination in leprosy. Scand J Immunol 63: 241-247.
26. Hasan Z, Zaidi I, Jamil B, Khan MA, Kanji A, (2005) Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunology 6 (14): 1-10.
27. Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, et al. (2004) MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 25: 1169-1173.
28. Gonzalez E, Rovin BH, Sen L, Cooke G, Dhanda R, et al. (2002) HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci USA 99: 13795-13800.
29. Tabara Y, Kohara K, Yamamoto Y, Igase M, Nakura J, et al. (2003) Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 26: 677-683.
30. Mori H, Kaneko Y, Narita I, Goto S, Saito N, et al. (2005) Monocyte chemoattractant protein-1 A-2518G gene polymorphism and renal survival of Japanese patients with immunoglobulin A nephropathy. Clin Exp Nephrol 9: 297-303.
31. Simeoni E, Hoffmann MM, Winkelmann BR, Ruiz J, Fleury S, et al. (2004) Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 47: 1574-1580.
32. Wright EK Jr, Page SH, Barber SA, Clements JE, (2008) Prep1/Pbx2 complexes regulate CCL2 expression through the-2578 guanine polymorphism. Genes Immun 9: 419-430.
33. Ansari A, Talat N, Jamil B, Hasan Z, Razzaki T, et al. (2009) Cytokine gene polymorphisms across tuberculosis clinical spectrum in Pakistani patients. PLoS ONE 4: e4778.
34. Talat N, Shahid F, Dawood G, Hussain R, (2009) Dynamic changes in biomarker profiles associated with clinical and subclinical tuberculosis in a high transmission setting: a four-year follow-up study. Scand J Immunol 69: 537-546.
35. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA, (1994) Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 91: 3652-3656.
36. Siveke JT, Hamann A, (1998) T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol 160: 550-554.
37. Mendez A, Hernandez-Pando R, Contreras S, Aguilar D, Rook GA, (2011) CCL2, CCL18 and sIL-4R in renal, meningeal and pulmonary TB; a 2 year study of patients and contacts. Tuberculosis (Edinb) 91: 140-145.
38. Tapaninen P, Korhonen A, Pusa L, Seppala I, Tuuminen T, (2010) Effector memory T-cells dominate immune responses in tuberculosis treatment: antigen or bacteria persistence? Int J Tuberc Lung Dis 14: 347-355.